Phase
Condition
Female Hormonal Deficiencies/abnormalities
Hemorrhage
Thrombocytopenic
Treatment
N/AClinical Study ID
Ages < 25 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adolescents and young adults aged < 26yo
Presenting to the gynecology consultation at HUG
Diagnosed with heavy menstrual bleeding (PBAC > 100)
Willing to initiate a hormonal medication to manage heavy menstrual bleeding
Exclusion
Exclusion Criteria:
Pregnancy or planning to become pregnant during the study period
Already using hormonal medication for menstrual management and/or contraception
Known anatomical uterine pathology
Using anticoagulant or antiaggregant agents
Study Design
Study Description
Connect with a study center
Geneva University Hospitals
Geneva, 1205
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.